A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax

Documenti analoghi

• Blastic plasmacytoid dendritic cell neoplasm ( BPDCN ): Morphological mimicry of lymphoid neoplasms
  di: Hong Guo, et al.
  Pubblicazione: (2026)
• A neonatal case of cutaneous blastic plasmacytoid dendritic cell neoplasm with transient regression
  di: Yuan Fang, et al.
  Pubblicazione: (2024)
• Correction to “Hematopoietic effects of tagraxofusp in treatment‐naive patients with blastic plasmacytoid dendritic cell neoplasm”
  Pubblicazione: (2026)
• Blastic plasmacytoid dendritic cell neoplasm (BPDCN) and mature plasmacytoid dendritic cell proliferation (MPDCP): the same cell of origin from a clonal haematopoiesis of indeterminate potential (CHIP)?
  di: Margherita Vannucchi, et al.
  Pubblicazione: (2025)
• Novel IKZF1 rearrangement identified in a patient with blastic plasmacytoid dendritic cell neoplasm decreased haematopoietic stem cell function and promoted plasmacytoid dendritic cell abnormality
  di: Le Yin, et al.
  Pubblicazione: (2024)